0000950170-24-081880.txt : 20240705 0000950170-24-081880.hdr.sgml : 20240705 20240705163011 ACCESSION NUMBER: 0000950170-24-081880 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240701 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20240705 DATE AS OF CHANGE: 20240705 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 241102871 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 awh-20240701.htm 8-K 8-K
false000092661700009266172024-07-012024-07-01

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 01, 2024

 

 

Aspira Women's Health Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-34810

33-0595156

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

12117 Bee Caves Road

Building III

Suite 100

 

Austin, Texas

 

78738

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 512 519-0400

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

AWH

 

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On July 1, 2024, Aspira Women’s Health Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company’s minimum Market Value of Listed Securities was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), Nasdaq has provided the Company with 180 calendar days, or until December 30, 2024 (the “Compliance Date”), to regain compliance with the MVLS Requirement. If the Company regains compliance with the MVLS Requirement, Nasdaq will provide written confirmation to the Company and close the matter.

The Notice does not result in the delisting of the Company’s common stock from the Nasdaq Capital Market. To regain compliance with the MVLS Requirement, the market value of the Company’s common stock must meet or exceed $35.0 million for a minimum of 10 consecutive business days during the 180-day grace period ending on the Compliance Date, unless the Staff exercises its discretion to extend this ten consecutive business day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H). The Company is evaluating potential actions to regain compliance with the MVLS Requirement and intends to actively monitor the market value of its listed securities. The Company may also, if appropriate, consider other options to regain compliance with Nasdaq’s continued listing standard such as by increasing its stockholders’ equity to at least $2.5 million.

In the event the Company does not regain compliance prior to the Compliance Date, the Company will receive written notification that its securities are subject to delisting, at which point the Company may appeal the delisting determination.

There can be no assurance that the Company will be successful in maintaining its listing of its common stock on the Nasdaq Capital Market.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

July 5, 2024

By:

/s/ Nicole Sandford

 

 

 

Nicole Sandford, Chief Executive Officer

 

 EX-101.SCH 2 awh-20240701.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document And Entity Information
Jul. 01, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 01, 2024
Entity Registrant Name Aspira Women's Health Inc.
Entity Central Index Key 0000926617
Entity Emerging Growth Company false
Entity File Number 001-34810
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 33-0595156
Entity Address, Address Line One 12117 Bee Caves Road
Entity Address, Address Line Two Building III
Entity Address, Address Line Three Suite 100
Entity Address, City or Town Austin
Entity Address, State or Province TX
Entity Address, Postal Zip Code 78738
City Area Code 512
Local Phone Number 519-0400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol AWH
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports awh-20240701.htm awh-20240701.xsd http://xbrl.sec.gov/dei/2024 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "awh-20240701.htm": { "nsprefix": "awh", "nsuri": "http://aspirawh.com/20240701", "dts": { "inline": { "local": [ "awh-20240701.htm" ] }, "schema": { "local": [ "awh-20240701.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 24 }, "report": { "R1": { "role": "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_c9c89200-ebbc-4162-8de0-4e350f1197d9", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "awh-20240701.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_c9c89200-ebbc-4162-8de0-4e350f1197d9", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "awh-20240701.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://aspirawh.com/20240701/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-081880-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-081880-xbrl.zip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awh-20240701_htm.xml IDEA: XBRL DOCUMENT 0000926617 2024-07-01 2024-07-01 false 0000926617 8-K 2024-07-01 Aspira Women's Health Inc. DE 001-34810 33-0595156 12117 Bee Caves Road Building III Suite 100 Austin TX 78738 512 519-0400 false false false false Common Stock, par value $0.001 per share AWH NASDAQ false